Latest News
View All
MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
Read more
MEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actions
Read more
MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights
Read more

Oncology Focused, Patient Centric

We are committed to the development of novel, best-in-class, cancer therapies intended to provide improved outcomes to patients

Our Clinical Trials
Our Clinical Trials
/pipeline/clinical-trials
Hematologic Malignancies
Hematologic Malignancies
/focus/hematologic-malignancies
Solid Tumors
Solid Tumors
/focus/solid-tumors
Delivering Benefit to Patients
Patients

Delivering Benefit to Patients

Our driving purpose and principle is simple: deliver novel, best-in-class, cancer therapies that provide improved outcomes for patients.
Patients